CN113604477A - Lilium regale defensin antibacterial peptide gene LrDEF1 and application - Google Patents
Lilium regale defensin antibacterial peptide gene LrDEF1 and application Download PDFInfo
- Publication number
- CN113604477A CN113604477A CN202110957485.3A CN202110957485A CN113604477A CN 113604477 A CN113604477 A CN 113604477A CN 202110957485 A CN202110957485 A CN 202110957485A CN 113604477 A CN113604477 A CN 113604477A
- Authority
- CN
- China
- Prior art keywords
- lrdef1
- plant
- gene
- tobacco
- antibacterial peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 44
- 241001634091 Lilium regale Species 0.000 title claims abstract description 18
- 108010002069 Defensins Proteins 0.000 title claims abstract description 14
- 102000000541 Defensins Human genes 0.000 title claims abstract description 13
- 239000003910 polypeptide antibiotic agent Substances 0.000 title claims abstract description 12
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims abstract description 35
- 241000208125 Nicotiana Species 0.000 claims abstract description 29
- 241000223221 Fusarium oxysporum Species 0.000 claims abstract description 13
- 239000002773 nucleotide Substances 0.000 claims abstract description 4
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 4
- 241001503951 Phoma Species 0.000 claims abstract description 3
- 241000879295 Fusarium equiseti Species 0.000 claims description 7
- 241001066584 Phoma neerlandica Species 0.000 claims description 4
- 241000196324 Embryophyta Species 0.000 abstract description 48
- 230000009261 transgenic effect Effects 0.000 abstract description 31
- 102000004169 proteins and genes Human genes 0.000 abstract description 19
- 230000000843 anti-fungal effect Effects 0.000 abstract description 8
- 244000061176 Nicotiana tabacum Species 0.000 abstract description 6
- 208000031888 Mycoses Diseases 0.000 abstract description 5
- 230000002018 overexpression Effects 0.000 abstract description 4
- 239000013604 expression vector Substances 0.000 abstract description 3
- 206010017533 Fungal infection Diseases 0.000 abstract description 2
- 208000015181 infectious disease Diseases 0.000 abstract description 2
- 238000011160 research Methods 0.000 abstract description 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 18
- 108020004414 DNA Proteins 0.000 description 17
- 241000234435 Lilium Species 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- 239000000047 product Substances 0.000 description 12
- 239000001963 growth medium Substances 0.000 description 11
- 239000013612 plasmid Substances 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000013598 vector Substances 0.000 description 10
- 241000233866 Fungi Species 0.000 description 9
- 239000002299 complementary DNA Substances 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 239000012634 fragment Substances 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 238000012216 screening Methods 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000000246 agarose gel electrophoresis Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 244000052616 bacterial pathogen Species 0.000 description 5
- 230000002538 fungal effect Effects 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 241000589158 Agrobacterium Species 0.000 description 4
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 4
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 4
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 244000053095 fungal pathogen Species 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 238000010353 genetic engineering Methods 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 238000003757 reverse transcription PCR Methods 0.000 description 4
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 102000012410 DNA Ligases Human genes 0.000 description 3
- 108010061982 DNA Ligases Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000223218 Fusarium Species 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000007123 defense Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 239000000575 pesticide Substances 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 241000123650 Botrytis cinerea Species 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 102100031780 Endonuclease Human genes 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000234280 Liliaceae Species 0.000 description 2
- 101000883593 Nicotiana alata Flower-specific defensin Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 241000682645 Phakopsora pachyrhizi Species 0.000 description 2
- AUJWXNGCAQWLEI-KBPBESRZSA-N Phe-Lys-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O AUJWXNGCAQWLEI-KBPBESRZSA-N 0.000 description 2
- 108010076504 Protein Sorting Signals Proteins 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 239000012881 co-culture medium Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000010195 expression analysis Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000010230 functional analysis Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 108010049041 glutamylalanine Proteins 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- AAQGRPOPTAUUBM-ZLUOBGJFSA-N Ala-Ala-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O AAQGRPOPTAUUBM-ZLUOBGJFSA-N 0.000 description 1
- JAMAWBXXKFGFGX-KZVJFYERSA-N Ala-Arg-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JAMAWBXXKFGFGX-KZVJFYERSA-N 0.000 description 1
- WQVYAWIMAWTGMW-ZLUOBGJFSA-N Ala-Asp-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N WQVYAWIMAWTGMW-ZLUOBGJFSA-N 0.000 description 1
- KJGNDQCYBNBXDA-GUBZILKMSA-N Arg-Arg-Cys Chemical compound C(C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)O)N)CN=C(N)N KJGNDQCYBNBXDA-GUBZILKMSA-N 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 241000222199 Colletotrichum Species 0.000 description 1
- 241000222239 Colletotrichum truncatum Species 0.000 description 1
- PRXCTTWKGJAPMT-ZLUOBGJFSA-N Cys-Ala-Ser Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O PRXCTTWKGJAPMT-ZLUOBGJFSA-N 0.000 description 1
- SRIRHERUAMYIOQ-CIUDSAMLSA-N Cys-Leu-Ser Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O SRIRHERUAMYIOQ-CIUDSAMLSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- CUXJIASLBRJOFV-LAEOZQHASA-N Glu-Gly-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O CUXJIASLBRJOFV-LAEOZQHASA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- TVTZEOHWHUVYCG-KYNKHSRBSA-N Gly-Thr-Thr Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O TVTZEOHWHUVYCG-KYNKHSRBSA-N 0.000 description 1
- DKJWUIYLMLUBDX-XPUUQOCRSA-N Gly-Val-Cys Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)O DKJWUIYLMLUBDX-XPUUQOCRSA-N 0.000 description 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- XZFYRXDAULDNFX-UHFFFAOYSA-N N-L-cysteinyl-L-phenylalanine Natural products SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 1
- 244000061322 Nicotiana alata Species 0.000 description 1
- 241000250031 Nicotiana megalosiphon Species 0.000 description 1
- KKYHKZCMETTXEO-AVGNSLFASA-N Phe-Cys-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KKYHKZCMETTXEO-AVGNSLFASA-N 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- CLKKNZQUQMZDGD-SRVKXCTJSA-N Ser-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CC1=CN=CN1 CLKKNZQUQMZDGD-SRVKXCTJSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000266365 Stemphylium vesicarium Species 0.000 description 1
- ASJDFGOPDCVXTG-KATARQTJSA-N Thr-Cys-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O ASJDFGOPDCVXTG-KATARQTJSA-N 0.000 description 1
- SHOMROOOQBDGRL-JHEQGTHGSA-N Thr-Glu-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O SHOMROOOQBDGRL-JHEQGTHGSA-N 0.000 description 1
- BIENEHRYNODTLP-HJGDQZAQSA-N Thr-Glu-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)O)N)O BIENEHRYNODTLP-HJGDQZAQSA-N 0.000 description 1
- KPMIQCXJDVKWKO-IFFSRLJSSA-N Thr-Val-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O KPMIQCXJDVKWKO-IFFSRLJSSA-N 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- VXCAZHCVDBQMTP-NRPADANISA-N Val-Cys-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N VXCAZHCVDBQMTP-NRPADANISA-N 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000004790 biotic stress Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229960002129 cefixime Drugs 0.000 description 1
- -1 cefixime sodium salt Chemical class 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- UCKZMPLVLCKKMO-LHLIQPBNSA-N cephamycin Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)[C@@H](C)[C@]21OC UCKZMPLVLCKKMO-LHLIQPBNSA-N 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- 108010081551 glycylphenylalanine Proteins 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical compound N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 108010057952 lysyl-phenylalanyl-lysine Proteins 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
Abstract
The invention discloses a Lilium regale defensin antibacterial peptide geneLrDef1The nucleotide sequence is shown as SEQ ID NO. 1, and the protein with the amino acid sequence shown as SEQ ID NO. 2 is coded, and the invention is proved by related technical research of functional genomicsLrDef1The gene has the function of improving the antifungal effect of plants, and the invention is antifungalLrDef1The gene is constructed on a plant expression vector and is transferred into tobacco for over-expression, a transgenic tobacco plant has strong capability of resisting fungal infection, and the experimental result shows that the over-expression is realizedLrDef1Transgenic tobacco of the strain can be used for treating fusarium oxysporum and phoma herbarumFusarium equiseti infection is highly resistant.
Description
Technical Field
The invention relates to the technical field related to molecular biology and genetic engineering, in particular to a Lilium regale defensin antibacterial peptide gene with antifungal infection capacityLrDef1And application thereof.
Background
Pathogenic bacteria are important influencing factors causing loss of plant yield and quality, and plant diseases caused by the pathogenic bacteria can reduce the yield of crops by 20-40%; wherein the fungal diseases are the largest number of plant diseases, and account for about 70-80% of the total number of the diseases. The traditional method for controlling plant diseases mainly uses chemical pesticides, improves cultivation management measures and cultivates new resistant varieties. Although the methods have certain effect, the traditional breeding period is long, the effect of cultivation measures is poor, and pesticides are easy to cause the problems of environmental safety, food safety and the like. With the rapid development of biotechnology, the new disease-resistant variety cultivated by using a genetic engineering method can overcome the defects of the prevention and treatment method, reduce the damage to beneficial microorganisms in soil to the maximum extent and realize the sustainable development of agriculture.
Plant Antimicrobial peptides (AMPs) are small, cysteine-rich, basic cationic peptides that are part of the plant immune system, have inhibitory or killing effects on pathogenic microorganisms such as bacteria, fungi and viruses, and play a crucial role in plant defense reactions (Zasloff Michael, Antimicrobial peptides of multicell organisms. Nature, 2002, 415 (6870): 389) -395). Plant defensins are important AMPs, and when plants are subjected to biotic stress, the plant defensins can be combined with specific characteristic membrane components of fungi to cause the cell membranes of pathogenic bacteria to be sunken, embedded into the cell membranes or transported into the cell membranes, so that a series of biochemical changes are generated.
Various defensin genes have been introduced into plants for enhancing plant resistance. Tobacco (A)Nicotiana megalosiphon) Defensins(NmDef02) Is a common plant defensin with antibacterial activity, and expressesNmDef02The transgenic soybean of (a), (b)Glycine max) Plant rust of soybean: (Phakopsora pachyrhizi) And anthrax bacteria (B)Colletotrichum truncatum) Show a higher resistance (Soto N, Y Hern ndz, Delgado C, et al. Field resistance toPhakopsora pachyrhizi and Colletotrichum truncatumof transgenic soybean expressing the NmDef02Plant defenses gene, Frontiers in Plant Science, 2020, 11: 562). In tobacco (A)N. alata) Separating to obtain a flower budNaD1The content of the defensin is as follows,NaD1can be specifically combined with The fungal Cell wall and enter The fungal cytoplasm, thereby triggering The rapid increase of The intracellular active oxygen concentration and leading The cytoplasmic membrane of The fungus to be permeabilized, and finally leading The fungal Cell to be dead (Baxter AA, Poon IK, Hulett MD. The plant defensen NaD1 indens Cell Death a non-apoptosis, molecular process, Cell Death Discovery, 2017, 3(1): 402-. In addition, NaD1 protein was specific for Fusarium oxysporum (F.), (Fusarium oxysporum) Botrytis cinerea (A), (B), (C), (B), (C), (B), (C), (B), (C), (B), (C), (B), (C)Botrytis cinerea) Candida, andCandida albicans) The various pathogenic fungi also have good antibacterial activity (Rao Yi, Zhao De just, Zhao Yi Gem, Gao Nicotiana tabacum)NaD1Prokaryotic expression and purification of genes molecular plant breeding 2020, 18(11): 3502-3508).
The Bulbus Lilii is Liliaceae (Liliaceae) Lilium (Lilium)Lilium) The plant is a general term of perennial root flower. During the processes of seed ball propagation and fresh cut flower production, lily is vulnerable to various pathogenic bacteria such as fungi, viruses and bacteria. The lily diseases found at present are more than dozens, among which, the lily is from the genus Fusarium (A), (B), (CFusarium spp.) blight caused by fungi (also known as basal rot, stem rot) is the most serious disease in lily production. After the fusarium infects the lily seed balls, the basal disc is necrotic, the scales are rotted and fall off, and the quality of the seed balls is reduced; after the plants are infected with fusarium, the leaves turn yellow and droop wilting, and the plants die in advance, so that the yield and the quality of cut lily flowers are seriously influenced; wherein the fusarium oxysporum has the strongest pathogenicity and separation frequencyMost importantly, the lily is the main pathogenic bacterium of lily wilt. Lilium regale (Lilium regale)L. regale Wilson) is a unique species in China, is only distributed in rock cracks from valleys with the altitude of 800-2700 m in Minjiang river basin to the mountains, has strong blight resistance, and is an important germplasm resource for modern lily breeding. The antibacterial peptide is an important component of a plant defense system, so that the antibacterial peptide has important research and application values on the discovery and functional analysis of the antibacterial peptide gene in Lilium regale.
Disclosure of Invention
The invention aims to provide a Lilium regale defensin antibacterial peptide geneLrDef1And application thereof, namely, the application of the composition in improving the resistance of tobacco to fusarium oxysporum (F)F. oxysporum) Phoma graminearum (A) and (B)Phoma herbarum) Fusarium equiseti (F.) hieron (F.)F. equiseti) Use in resistance.
The defensein antibacterial peptide gene with antifungal activity, which is cloned from Lilium regaleLrDef1,LrDef1The nucleotide sequence is shown as SEQ ID NO. 1, the gene cDNA full length sequence is 501bp, comprises a 225bp open reading frame, a 37 bp 5 'untranslated region and a 239 bp 3' untranslated region, and codes the protein of the amino acid sequence shown as SEQ ID NO. 2.
In the inventionLrDef1The coding region of the gene is a nucleotide sequence shown in 38 th to 262 th sites in a sequence table SEQ ID NO. 1.
The invention separates and clones a complete cDNA segment of an antifungal related gene of Lilium regale, and utilizes agrobacterium tumefaciens (A), (B) and (C)Agrobacterium tumefaciens) The target gene is transferred into a receptor plant and is overexpressed, whether the gene has antifungal activity is verified through further experiments, a foundation is laid for the capability of improving tobacco and other plants to resist fungal diseases by utilizing the gene in the later period, and the inventor names the gene asLrDef1。
As described aboveLrDef1The gene can be applied to improving the antifungal property of tobacco, and the specific operation is as follows:
(1) using amplificationLrDef1The specific primer is used for extracting total RNA from Lilium regale roots inoculated with fusarium oxysporum and performing reverse transcription-polymerase chain reactionShould be (reverse transcription-polymerase chain reaction, RT-PCR) amplifiedLrDef1Then connecting the full-length coding region to a pGEM-T vector, and obtaining a clone with a target gene through sequencing;
(2) using restriction endonucleasesEcoRI andBamh I enzyme digestion pGEM-T-LrDef1Recovering the carrier by glue to obtain target gene segment, using the same endonuclease to enzyme-cut plant expression carrier pCAMBIA2300s, recovering the glue to obtain the required carrier large segment, and recovering the obtained carrier large segmentLrDef1Connecting the gene fragment with the pCAMBIA2300s fragment to construct a plant overexpression vector, and then transferring the constructed recombinant vector into tobacco to express through the mediation of agrobacterium tumefaciens;
(3) screening transformants by using a resistance marker on the recombinant vector T-DNA, obtaining a real transgenic plant through PCR and RT-PCR detection, analyzing the inhibition capability of total protein of a transgenic plant leaf on the growth of pathogenic fungi, and finally screening the transgenic plant with obviously enhanced resistance to the fungi.
The invention provides a new method for improving the resistance of plants to fungal diseases, the defects of traditional breeding can be overcome by cultivating disease-resistant plants by means of genetic engineering, the breeding period is shortened, the operation is simple, and high-resistance materials are easy to obtain. The invention is derived from Lilium regaleLrDef1The gene can enhance the resistance of plants to fungi, and the gene is introduced into tobacco, so that new varieties and new materials with fungal resistance can be generated; the cultivation of resistant plant varieties and materials by utilizing the genetic engineering technology has obvious advantages and irreplaceable importance; the invention not only can provide convenience for large-scale production of crops, medicinal materials, horticultural plants and the like, greatly reduces the use of chemical pesticides, but also can save the cost for agricultural production and reduce the environmental pollution, thereby having wide market application prospect.
Drawings
FIG. 1 is a drawing of the present inventionLrDef1PCR detection result graph of transgenic tobacco genome DNA, in the graph: the Marker is DL2000 DNA Marker (Dalibao biology); the positive control is plasmid pGEM-T-LrDef1A PCR product as a template; WT is the total DNA of non-transgenic tobacco (wild type)The product of plate PCR;
FIG. 2 shows the positivity of the present inventionLrDef1In transgenic tobaccoLrDef1A graph of the results of expression analysis at the transcriptional level; in the figure: marker is DL2000 DNA Marker (Dalibao biology); WT is a PCR product with non-transgenic tobacco total RNA reverse transcription cDNA as a template; the positive control was plasmid pGEM-T-LrDef1A PCR product as a template;
FIG. 3 is a drawing of the present inventionLrDef1A bacteriostatic effect graph of the transgenic tobacco on the growth of pathogenic fungi in vitro; the fungi shown in panels a, b, c are respectively Phoma herbarum (P. herbarum) Fusarium equiseti (F.) hieron (F.)F. equiseti) Fusarium oxysporum (F.), (F. oxysporum) (ii) a WT was the wild type tobacco total protein and Buffer was the blank, i.e., no protein control (Buffer used to extract protein).
Detailed Description
The present invention is further illustrated by the following figures and examples, but the scope of the present invention is not limited to the above description, and the examples are conventional methods unless otherwise specified, and reagents used are conventional commercially available reagents or reagents formulated according to conventional methods unless otherwise specified.
Example 1:LrDef1gene cloning and sequence analysis
Inoculating fusarium oxysporum to Lilium regale, extracting total RNA from roots inoculated for 24 hours, grinding the inoculated Lilium regale roots into powder by using liquid nitrogen, transferring the powder into a centrifuge tube, extracting the total RNA by using a guanidine isothiocyanate method, synthesizing a cDNA first chain by using reverse transcriptase M-MLV (promega) and using the total RNA as a template, wherein a reaction system and an operation process are as follows: mu.g of total RNA was taken and added with 50ng oligo (dT), 2. mu.L dNTP (2.5 mM) and DEPC water in sequence to a reaction volume of 14.5. mu.L; after uniformly mixing, heating and denaturing at 70 ℃ for 5min, then rapidly cooling on ice for 5min, then sequentially adding 4 mu L of 5 XFirst-stand buffer, 0.5 mu L of RNase (200U) and 1 mu L M-MLV (200U), uniformly mixing and centrifuging for a short time, carrying out warm bath at 42 ℃ for 1.5h, taking out, heating at 70 ℃ for 10min, and stopping reaction; the first strand cDNA is synthesized and stored at-20 deg.C for further use.
Amplifying target gene using synthesized first strand cDNA as templateLrDef1Use ofThe upstream and downstream primer sequences were 5 'TCGTCGTCCCCATCTCAG 3' and 5 'AAATACAAGAGAACTTACTCCA 3' respectively. Advantage is takenTM2 PCR Enzyme (Clontech) amplifies the target gene; and (3) PCR reaction conditions: 5min at 94 ℃; 30s at 94 ℃, 30s at 54 ℃, 30s at 72 ℃ and 32 cycles; 7min at 72 ℃; the reaction system (20. mu.L) was 0.5. mu.L of cDNA, 2. mu.L of 10 × Advantage 2 PCR Buffer, 0.4. mu.L of 50 × dNTP Mix (10 mM each), 0.4. mu.L of forward primer (10. mu.M), 0.4. mu.L of reverse primer (10. mu.M), 0.4. mu.L of Advantage 2 PCR Polymerase Mix, 15.9. mu.L of PCR-Grade water; after the PCR was completed, 5. mu.L of the resulting mixture was subjected to agarose gel electrophoresis to examine the specificity and size of the amplified product.
The PCR product was TA cloned using pGEM-T Vector System I (Promega, USA) as a kit, and the reaction System and procedure were as follows: mu.L of the PCR product was taken, and 1. mu.L of pGEM-T Vector (50 ng/. mu.L) and 2.5. mu.L of 2 × Ligation solution I were sequentially added thereto, mixed well and then left to react at 16 ℃ overnight. The ligation product was transformed into E.coli DH 5. alpha. using a heat shock transformation method. Screening positive clones with LB solid medium containing ampicillin (Ampicillin, Amp), selecting several single colonies, shaking, and amplifyingLrDef1Identifying the multiple cloning site insertionLrDef1The clones identified are sequenced and finally obtainedLrDef1The full-length cDNA was 501bp, which was found to contain a 225bp open reading frame by NCBI ORF finder (http:// www.ncbi.nlm.nih.gov/gorf. html) analysis (see sequence listing),LrDef1encodes a 74 amino acid protein with a molecular weight of about 8.06kDa and an isoelectric point of about 8.22. Analysis by means of bioinformatics software SignalP 5.0LrDef1The encoded protein sequence, and detecting whether the protein sequence has an N-terminal signal peptide. The results showed that a signal peptide was present at the N-terminus of LrDef1, and thus the protein was presumed to be a secreted protein.
Example 2: construction of plant overexpression vectors
The insertion is extracted by adopting a SanPrep column type plasmid DNA small extraction kit (Shanghai worker)LrDef1The E.coli plasmid pGEM-T-LrDef1And the plasmid of the plant expression vector pCAMBIA2300s, taking 1 μ L to be used in agarose gelElectrophoresis is carried out to detect the integrity and concentration of the extracted plasmid; using restriction endonucleasesEcoRI (TaKaRa) andBamHI (TaKaRa) against plasmid pGEM-T-LrDef1And pCAMBIA2300s (100 mu L system), wherein the reaction system and the operation process are as follows: taking 20. mu.L of pGEM-T-LrDef1And pCAMBIA2300s plasmid, 10. mu.L 10 XK buffer, and 4. mu.LEcoRI、6μL BamHI、60μL ddH2O, mixing uniformly, centrifuging for a short time, and reacting at 37 ℃ overnight; all the products of the digestion are spotted in agarose gel for electrophoresis, and thenLrDef1The fragments and the pCAMBIA2300s vector large fragment are respectively subjected to gel recovery, and a SanPrep column type DNA gel recovery kit (Shanghai's engineering) is used in the whole process; taking 1 microliter of the recovered product, detecting the size and concentration of the recovered fragment by agarose gel electrophoresis, and storing at-20 ℃ for later use.
The recovered DNA was purified by using T4 DNA Ligase (TaKaRa)LrDef1 The DNA fragment and the pCAMBIA2300s vector fragment were ligated, and the reaction system (20. mu.L) and the procedure were as follows: taking 10 μ LLrDef1 The DNA fragment was sequentially added with 2. mu.L of pCAMBIA2300s vector DNA, 2. mu.L of 10 XT 4 DNA Ligase Buffer, 1. mu. L T4 DNA Ligase, and 5. mu.L of ddH2And O, mixing uniformly, centrifuging for a short time, and then carrying out water bath at 16 ℃ for overnight reaction. Then transferring the ligation product into Escherichia coli DH5 alpha by heat shock transformation, screening positive clones with solid culture medium containing 50mg/L kanamycin (Km), selecting single colony shake bacteria, and amplifying with bacteria liquid as templateLrDef1The specific primers of (1) are subjected to PCR, and selectedLrDef1If the detected strain is positive, the clone successfully connected with pCAMBIA2300s is added with glycerol and stored at-80 ℃ for later use.
Extraction and purification of pCAMBIA2300s-LrDef1Plasmid, then freezing and thawing the plant expression vector pCAMBIA2300s-LrDef1Transferred into Agrobacterium tumefaciens LBA4404 competent cells. The operation steps are as follows: taking 2 μ g of pCAMBIA2300s-LrDef1Adding plasmid into a centrifuge tube containing 200 μ L competent cells, mixing, ice-cooling for 5min, transferring into liquid nitrogen, freezing for 1min, rapidly placing in 37 deg.C water bath for 5min, immediately ice-cooling for 2min, adding 800Mu L LB liquid culture base on 28 ℃ shaking culture for 4 h; coating the activated agrobacterium on LB solid culture medium with 50mg/L Km, and statically culturing at 28 ℃; selecting single colony shake bacteria, and amplifyingLrDef1The specific primer of (2) is used for PCR to detect pCAMBIA2300s-LrDef1If the positive clone is transferred into agrobacterium, adding glycerol into the positive clone, and storing the positive clone at-80 ℃ for later use.
Example 3: agrobacterium-mediated genetic transformation of plants and transgenic plant screens
The transgenic recipient in this experiment was tobacco, tobacco seeds were soaked in 75% ethanol for 30s, washed with sterile water and then washed with 0.1% HgCl2Soaking for 8min, washing with sterile water for several times, sowing on 1/2 MS culture medium, dark culturing at 28 deg.C for 6d, germinating, transferring to light incubator (25 deg.C, 16 h/d light), and subculturing with 1/2 MS culture medium once a month.
The preserved liquid containing pCAMBIA2300s was taken out from the-80 ℃ refrigeratorLrDef1Agrobacterium LBA4404 strain of plasmid was inoculated into 5mL LB liquid medium containing 50mg/L Km and 20mg/L rifampicin, and cultured at 28 ℃ until the medium became turbid. Sucking 1mL of turbid bacterial liquid to an LB solid culture medium containing 50mg/L Km, and culturing for 48 h at 28 ℃; then, appropriate amount of the agrobacteria on LB solid medium was scraped and inoculated into MGL liquid medium supplemented with 20mg/L acetosyringone, and shake-cultured at 28 ℃ for 2-3h to activate the agrobacteria.
Cutting sterile tobacco seedling leaf into 1 cm2And completely soaking the left and right leaf discs in the MGL liquid culture medium containing the activated agrobacterium for 15min, sucking bacterial liquid on the surfaces of the leaves by using sterile filter paper, placing the leaf discs on a co-culture medium for room temperature culture, wherein the co-culture medium for tobacco transformation is MS +0.02 mg/L6-BA +2.1mg/L NAA +30g/L sucrose +6g/L agar, and co-culturing for 2 days at 22 ℃ in the absence of light.
Transferring the co-cultured leaf discs to an MS screening culture medium added with antibiotics to be divided into seedlings, and screening transgenic plants; the tobacco screening culture medium is MS +0.5 mg/L6-BA +0.1mg/L NAA +30g/L sucrose +6g/L agar +50mg/L Km +200 mg/L cephamycin (cefixime sodium salt, Cef); during screening culture, the culture bottle is transferred to an illumination culture box for culture (25 ℃, 16 h/d illumination and 8 h/d darkness), after the tobacco grows out of buds, the MS culture medium containing 50mg/L Km and 200mg/L Cef is used for subculture, the regeneration plant needs to be further screened because the callus differentiation rate of the tobacco is higher, the tobacco regeneration seedling is transferred to the MS culture medium containing 50mg/L Km to root the tobacco regeneration seedling, and finally the regeneration seedling with better rooting is selected for further detection.
Extracting genome DNA of transgenic tobacco plant leaf by CTAB method, collecting 1 μ L of the extracted genome DNA, detecting its integrity and concentration by agarose gel electrophoresis, and amplifying with the genome DNA of transgenic plant as templateLrDef1After the PCR is finished, 8 mu L of the product is used for agarose gel electrophoresis to detect positive transgenic plants, the amplification result of part of transgenic tobacco is shown in figure 1, and 30 positive transgenic tobacco plants are screened out altogether.
Example 4: in transgenic tobaccoLrDef1Expression analysis and functional analysis of transgenic plants against fungal infection
Taking positive transgenic single plant and tender leaf of non-transgenic tobacco (wild type) to extract total RNA, reverse transcribing to generate first strand cDNA, and using it as template to make amplificationLrDef1The specific primers are used for carrying out PCR, and each transgenic individual is analyzed according to the PCR resultLrDef1The expression of transcription level, total RNA extraction and RT-PCR were performed as in example 1, after PCR was completed, 8. mu.L of the DNA was subjected to agarose gel electrophoresis, and the results of detection of some individuals were shown in FIG. 2, and 20 transgenic individuals were detected in totalLrDef1The expression was carried out at the transcriptional level, and the individuals were numbered L1-L20.
Several kinds of pathogenic fungi stored in a laboratory are inoculated on a PDA solid culture medium (200 g/L of potato, 15g/L of agar and 20g/L of glucose), dark culture is carried out at 28 ℃, plant protein is added when bacterial colonies grow to be about 2-3cm in diameter, and the in-vitro antifungal activity of transgenic plants is analyzed. In order to prevent other bacteria from polluting the extracted protein, the whole process of extracting the vegetable protein is aseptic operation. Firstly, 1g of transgenic tobacco single plant (numbered L-8, L-9 and L-16 respectively) and wild type leaf are put into a mortar, and 1mL of protein extract (1M NaCL and 0)1M sodium acetate, 1% PVP, ph6.0), triturated well. Transferring into a 1.5mL centrifuge tube, mixing uniformly, and standing overnight at 4 ℃. Centrifuge at 4 deg.C for 30min (12,000g/min), take the supernatant in a new 1.5mL centrifuge tube, and take an appropriate amount to determine the total protein concentration with an ultraviolet spectrophotometer. The total protein concentration of the transgenic and wild type plants was adjusted to 0.2. mu.g/. mu.L, and then 20. mu.L of each was dropped onto sterile filter paper of each fungal culture. In addition to the total protein of the different transgenic tobacco plants, the total protein of the wild type tobacco and a blank (protein extract) were added in parallel to each fungal plate. The growth of the fungus was observed after several days of cultivation at 28 ℃ and evaluated based on the observationLrDef1The results of the in vitro antifungal activity of the transgenic tobacco are shown in FIG. 3,LrDef1the transgenic tobacco protein has obvious inhibition effect on the growth of fusarium oxysporum, phoma herbarum and fusarium equiseti.
Sequence listing
<110> university of Kunming science
<120> Lilium regale defensin antibacterial peptide gene LrDEF1 and application
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 501
<212> DNA
<213> Lilium regale Wilson
<400> 1
tcgtcgtccc catctcagtg gccgactatc tcttgcaatg gcgaagcttc ccaccatcct 60
gctgctcttg ttccttgtca tggccactga gatggggacg acgacggtgg aggcgaggac 120
atgcctgtcg cagagccaca agttcaaggg gacctgtttg agggcggcca actgtgctag 180
tgtctgccag acggagggat tcaaaggagg ggtttgcgag ggcatccgcc gccgttgctt 240
ctgcgaagcc gactgtcact gatgcctgag ttcttggctt taataagtaa tgtcggacta 300
tccgagaaga ataagatgga cctggtgttg ttggttttac agtctcttct tcggtgtggg 360
gactcggtac tttcatctag gtttctgata tgtagttgtt catgtctggg ttgagctgta 420
gggctgtgtg ctgtagttgg atttgtagtg gagtaagttc tcttgtattt gatttgtagt 480
ggagtaagtt ctcttgtatt t 501
<210> 2
<211> 74
<212> PRT
<213> Lilium regale Wilson
<400> 2
Met Ala Lys Leu Pro Thr Ile Leu Leu Leu Leu Phe Leu Val Met Ala
1 5 10 15
Thr Glu Met Gly Thr Thr Thr Val Glu Ala Arg Thr Cys Leu Ser Gln
20 25 30
Ser His Lys Phe Lys Gly Thr Cys Leu Arg Ala Ala Asn Cys Ala Ser
35 40 45
Val Cys Gln Thr Glu Gly Phe Lys Gly Gly Val Cys Glu Gly Ile Arg
50 55 60
Arg Arg Cys Phe Cys Glu Ala Asp Cys His
65 70
<210> 3
<211> 18
<212> DNA
<213> Artificial sequence (Artificial)
<400> 3
tcgtcgtccc catctcag 18
<210> 4
<211> 22
<212> DNA
<213> Artificial sequence (Artificial)
<400> 4
aaatacaaga gaacttactc ca 22
Claims (2)
1. Lilium regale defensin antibacterial peptide groupDue to the fact thatLrDef1The nucleotide sequence is shown in SEQ ID NO. 1.
2. The Lilium regale defensin antibacterial peptide gene as claimed in claim 1LrDef1In increasing the resistance of tobacco to fusarium oxysporum (F.), (Fusarium oxysporum) Phoma graminearum (A) and (B)Phoma herbarum) Fusarium equiseti (F.) hieron (F.)Fusarium equiseti) Use in resistance.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110957485.3A CN113604477B (en) | 2021-08-20 | 2021-08-20 | Lilium regale defensin antibacterial peptide gene LrDEF1 and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110957485.3A CN113604477B (en) | 2021-08-20 | 2021-08-20 | Lilium regale defensin antibacterial peptide gene LrDEF1 and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113604477A true CN113604477A (en) | 2021-11-05 |
CN113604477B CN113604477B (en) | 2023-03-24 |
Family
ID=78341409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110957485.3A Active CN113604477B (en) | 2021-08-20 | 2021-08-20 | Lilium regale defensin antibacterial peptide gene LrDEF1 and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113604477B (en) |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008018488A1 (en) * | 2006-08-09 | 2008-02-14 | Takara Bio Inc. | Antibacterial agent |
CN103194456A (en) * | 2013-04-24 | 2013-07-10 | 昆明理工大学 | Lilium regale antifungal gene Lr14-3-3 and application thereof |
WO2014078900A1 (en) * | 2012-11-23 | 2014-05-30 | Hexima Limited | Anti-pathogenic methods |
CN103834665A (en) * | 2012-11-23 | 2014-06-04 | 赫希玛有限公司 | Use of anti-fungal defensins |
CN105861517A (en) * | 2016-04-20 | 2016-08-17 | 昆明理工大学 | Panax notoginseng antimicrobial peptide gene PnSN1 and application thereof |
CN105968177A (en) * | 2016-05-06 | 2016-09-28 | 广州大学 | Banana antibacterial peptide MaSN2 and novel application of gene thereof |
CN108707610A (en) * | 2018-05-04 | 2018-10-26 | 昆明理工大学 | Radix Notoginseng defensin antibacterial peptide genes PnDEFL1 and application |
CN110446721A (en) * | 2017-01-23 | 2019-11-12 | 因内特免疫有限公司 | For protecting host from the composition and method of pathogenic infection |
CN110734482A (en) * | 2019-11-13 | 2020-01-31 | 昆明理工大学 | Lilium regale WRKY transcription factor gene LrWRKY4 and application thereof |
CN110818782A (en) * | 2019-11-13 | 2020-02-21 | 昆明理工大学 | Lilium regale WRKY transcription factor gene LrWRKY3 and application thereof |
CN110818783A (en) * | 2019-11-13 | 2020-02-21 | 昆明理工大学 | Lilium regale WRKY transcription factor gene LrWRKY2 and application thereof |
CN111235165A (en) * | 2020-04-02 | 2020-06-05 | 长江师范学院 | Lily susceptible fungal gene LrWRKY-S1 and application thereof |
CN112359049A (en) * | 2020-12-10 | 2021-02-12 | 昆明理工大学 | Lilium regale chitinase gene LrCHI2 and application thereof |
CN113603757A (en) * | 2021-08-20 | 2021-11-05 | 昆明理工大学 | Lilium regale Dirigent similar protein gene LrDI 1 and application |
-
2021
- 2021-08-20 CN CN202110957485.3A patent/CN113604477B/en active Active
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008018488A1 (en) * | 2006-08-09 | 2008-02-14 | Takara Bio Inc. | Antibacterial agent |
WO2014078900A1 (en) * | 2012-11-23 | 2014-05-30 | Hexima Limited | Anti-pathogenic methods |
CN103834665A (en) * | 2012-11-23 | 2014-06-04 | 赫希玛有限公司 | Use of anti-fungal defensins |
CN103194456A (en) * | 2013-04-24 | 2013-07-10 | 昆明理工大学 | Lilium regale antifungal gene Lr14-3-3 and application thereof |
CN105861517A (en) * | 2016-04-20 | 2016-08-17 | 昆明理工大学 | Panax notoginseng antimicrobial peptide gene PnSN1 and application thereof |
CN105968177A (en) * | 2016-05-06 | 2016-09-28 | 广州大学 | Banana antibacterial peptide MaSN2 and novel application of gene thereof |
CN110446721A (en) * | 2017-01-23 | 2019-11-12 | 因内特免疫有限公司 | For protecting host from the composition and method of pathogenic infection |
CN108707610A (en) * | 2018-05-04 | 2018-10-26 | 昆明理工大学 | Radix Notoginseng defensin antibacterial peptide genes PnDEFL1 and application |
CN110734482A (en) * | 2019-11-13 | 2020-01-31 | 昆明理工大学 | Lilium regale WRKY transcription factor gene LrWRKY4 and application thereof |
CN110818782A (en) * | 2019-11-13 | 2020-02-21 | 昆明理工大学 | Lilium regale WRKY transcription factor gene LrWRKY3 and application thereof |
CN110818783A (en) * | 2019-11-13 | 2020-02-21 | 昆明理工大学 | Lilium regale WRKY transcription factor gene LrWRKY2 and application thereof |
CN111235165A (en) * | 2020-04-02 | 2020-06-05 | 长江师范学院 | Lily susceptible fungal gene LrWRKY-S1 and application thereof |
CN112359049A (en) * | 2020-12-10 | 2021-02-12 | 昆明理工大学 | Lilium regale chitinase gene LrCHI2 and application thereof |
CN113603757A (en) * | 2021-08-20 | 2021-11-05 | 昆明理工大学 | Lilium regale Dirigent similar protein gene LrDI 1 and application |
Non-Patent Citations (5)
Title |
---|
LIU,D.等: "Lilium regale defensin (Def1) mRNA, complete cds", 《GENBANK DATABASE》 * |
NCBI: "PREDICTED: Brachypodium distachyon defensin Tm-AMP-D1.2 (LOC100844099), mRNA", 《GENBANK DATABASE》 * |
ZIE WANG等: "Lilium regale Wilson WRKY3 modulates an antimicrobial peptide gene, LrDef1,during response to Fusarium oxysporum", 《BMC PLANT BIOLOGY》 * |
梁巧兰等: "深绿木霉蛋白质TraT2A诱导兰州百合抗灰霉病的作用", 《中国生物防治学报》 * |
王自娥等: "岷江百合WRKY转录因子基因的克隆与功能分析", 《西北植物学报》 * |
Also Published As
Publication number | Publication date |
---|---|
CN113604477B (en) | 2023-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110818783B (en) | Lilium regale WRKY transcription factor gene LrWRKY2 and application thereof | |
CN105441460B (en) | A kind of Ming River lily WRKY transcription factor genes LrWRKY1 and application | |
CN110818782B (en) | Lilium regale WRKY transcription factor gene LrWRKY3 and application thereof | |
CN107936104B (en) | Peony PsMYB12 transcription factor and coding gene and application thereof | |
CN110747202B (en) | Lilium regale WRKY transcription factor gene LrWRKY11 and application thereof | |
CN110734482B (en) | Lilium regale WRKY transcription factor gene LrWRKY4 and application thereof | |
CN112831505B (en) | Pseudo-ginseng WRKY transcription factor gene PnWRKY15 and application thereof | |
CN111235165B (en) | Lily susceptible fungal gene LrWRKY-S1 and application thereof | |
CN108251432B (en) | Notoginseng disease course related protein genePnPRlikeAnd applications | |
CN112831504A (en) | Pseudo-ginseng WRKY transcription factor genePnWRKY9And uses thereof | |
CN109536516B (en) | Cloning and application of corn drought-resistant gene ZmDSR | |
CN112359049B (en) | Lilium regale chitinase gene LrCHI2 and application thereof | |
CN107267526A (en) | Pseudo-ginseng myb transcription factor gene PnMYB2 and its application | |
CN114317552A (en) | Gene PeERF1 for regulating and controlling salt tolerance of populus euphratica and application thereof | |
CN110819634B (en) | Clone of lilium tenuifolium gene LpNAC6 and application thereof | |
CN103320448B (en) | Lilium regle bZIP transcription factor LrbZIP1 and application | |
CN107267525B (en) | Application of panax notoginseng polygalacturonase inhibitor protein gene PnPGIP | |
CN113603757B (en) | Lily regale Dirigent similar protein gene LrDIR1 and application thereof | |
CN113604477B (en) | Lilium regale defensin antibacterial peptide gene LrDEF1 and application thereof | |
CN109295068B (en) | Pseudo-ginseng sweet protein gene PnTLP2 and application | |
CN108707610B (en) | Notoginseng defensein antibacterial peptide genePnDEFL1And applications | |
CN107326018B (en) | Method for cultivating plant low temperature resistant gene and transgenic low temperature resistant plant | |
CN106701780B (en) | PgAG gene for regulating development of pomegranate ovule and application thereof | |
CN108707611B (en) | Pseudo-ginseng reverse osmosis protein genePnOLP1And applications | |
CN109234284B (en) | Pseudo-ginseng sweet protein gene PnTLP5 and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |